Loading...
XNAS
GCTK
Market cap3mUSD
Dec 05, Last price  
6.00USD
1D
0.33%
1Q
22.70%
IPO
-92.62%
Name

GlucoTrack Inc

Chart & Performance

D1W1MN
XNAS:GCTK chart
P/E
0.15
P/S
EPS
39.82
Div Yield, %
Shrs. gr., 5y
-50.01%
Rev. gr., 5y
8.45%
Revenues
0k
0000059,775143,167611,689589,46243,488208,76200000
Net income
23m
P
-1,202,296-2,788,446-2,364,339-2,772,307-9,796,8532,980,426-5,842,172-5,409,737-10,328,806-6,715,420-3,516,189-2,598,000-4,100,000-4,438,000-7,097,00022,597,000
CFO
-12m
L+90.45%
-1,367,837-1,916,113-2,296,989-3,217,767-3,361,645-4,565,224-5,311,830-5,895,119-4,892,277-3,899,087-3,501,000-3,769,000-3,729,000-6,558,000-12,490,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
IPO date
Apr 09, 2013
Employees
Domiciled in
IL
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT